163 related articles for article (PubMed ID: 31757841)
21. Variability of dynamic 18F-FDG-PET data in breast cancer xenografts.
Pitman KE; Rusten E; Kristian A; Malinen E
Acta Oncol; 2015; 54(9):1399-407. PubMed ID: 26217987
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive
Henry KE; Dilling TR; Abdel-Atti D; Edwards KJ; Evans MJ; Lewis JS
J Nucl Med; 2018 Jan; 59(1):51-57. PubMed ID: 28848040
[TBL] [Abstract][Full Text] [Related]
23. The utility of
Kitajima K; Kawanaka Y; Komoto H; Minami T; Yokoi T; Kuribayashi K; Kijima T; Nakamura A; Hashimoto M; Kondo N; Hasegawa S; Yamakado K
Hell J Nucl Med; 2021; 24(3):186-198. PubMed ID: 34901959
[TBL] [Abstract][Full Text] [Related]
24. Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts.
Kristian A; Revheim ME; Qu H; Mælandsmo GM; Engebråten O; Seierstad T; Malinen E
Acta Oncol; 2013 Oct; 52(7):1566-72. PubMed ID: 23984812
[TBL] [Abstract][Full Text] [Related]
25. Measurement Repeatability of
Fraum TJ; Fowler KJ; Crandall JP; Laforest RA; Salter A; An H; Jacobs MA; Grigsby PW; Dehdashti F; Wahl RL
J Nucl Med; 2019 Aug; 60(8):1080-1086. PubMed ID: 30733325
[TBL] [Abstract][Full Text] [Related]
26. Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial.
Machtay M; Duan F; Siegel BA; Snyder BS; Gorelick JJ; Reddin JS; Munden R; Johnson DW; Wilf LH; DeNittis A; Sherwin N; Cho KH; Kim SK; Videtic G; Neumann DR; Komaki R; Macapinlac H; Bradley JD; Alavi A
J Clin Oncol; 2013 Oct; 31(30):3823-30. PubMed ID: 24043740
[TBL] [Abstract][Full Text] [Related]
27. Total metabolic tumor volume on
Tricarico P; Chardin D; Martin N; Contu S; Hugonnet F; Otto J; Humbert O
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38649279
[TBL] [Abstract][Full Text] [Related]
28. Assessing the variability and correlation between SUV and ADC parameters of head and neck cancers derived from simultaneous PET/MRI: A single-center study.
Wongsa P; Nantasuk M; Singhnoi S; Pawano P; Jantarato A; Siripongsatian D; Lerdsirisuk P; Phonlakrai M
J Appl Clin Med Phys; 2023 May; 24(5):e13928. PubMed ID: 36763489
[TBL] [Abstract][Full Text] [Related]
29. 18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes.
Koo HR; Park JS; Kang KW; Cho N; Chang JM; Bae MS; Kim WH; Lee SH; Kim MY; Kim JY; Seo M; Moon WK
Eur Radiol; 2014 Mar; 24(3):610-8. PubMed ID: 24097303
[TBL] [Abstract][Full Text] [Related]
30. Relationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast cancer.
Soussan M; Orlhac F; Boubaya M; Zelek L; Ziol M; Eder V; Buvat I
PLoS One; 2014; 9(4):e94017. PubMed ID: 24722644
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity derived from
Xie Y; Liu C; Zhao Y; Gong C; Li Y; Hu S; Song S; Hu X; Yang Z; Wang B
Cancer Med; 2022 May; 11(9):1948-1955. PubMed ID: 35275444
[TBL] [Abstract][Full Text] [Related]
32. Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from
Kim YI; Kim YJ; Paeng JC; Cheon GJ; Lee DS; Chung JK; Kang KW
Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1787-1795. PubMed ID: 28616695
[TBL] [Abstract][Full Text] [Related]
33. Prospective comparison of early interim
Su TP; Huang JS; Chang PH; Lui KW; Hsieh JC; Ng SH; Chan SC
BMC Cancer; 2021 Aug; 21(1):908. PubMed ID: 34376155
[TBL] [Abstract][Full Text] [Related]
34. Magnetic Resonance Imaging Is More Sensitive Than PET for Detecting Treatment-Induced Cell Death-Dependent Changes in Glycolysis.
Hesketh RL; Wang J; Wright AJ; Lewis DY; Denton AE; Grenfell R; Miller JL; Bielik R; Gehrung M; Fala M; Ros S; Xie B; Hu DE; Brindle KM
Cancer Res; 2019 Jul; 79(14):3557-3569. PubMed ID: 31088837
[TBL] [Abstract][Full Text] [Related]
35. Additional value of
van Ramshorst MS; Teixeira SC; Koolen BB; Pengel KE; Gilhuijs KG; Wesseling J; Rodenhuis S; Valdés Olmos RA; Rutgers EJ; Vogel WV; Sonke GS; Vrancken Peeters MT
Cancer Imaging; 2017 May; 17(1):15. PubMed ID: 28545563
[TBL] [Abstract][Full Text] [Related]
36. Pretreatment
Gong C; Ma G; Hu X; Zhang Y; Wang Z; Zhang J; Zhao Y; Li Y; Xie Y; Yang Z; Wang B
Oncologist; 2018 Oct; 23(10):1144-1152. PubMed ID: 30082489
[TBL] [Abstract][Full Text] [Related]
37. Imaging of treatment response to the combination of carboplatin and paclitaxel in human ovarian cancer xenograft tumors in mice using FDG and FLT PET.
Munk Jensen M; Erichsen KD; Björkling F; Madsen J; Jensen PB; Sehested M; Højgaard L; Kjær A
PLoS One; 2013; 8(12):e85126. PubMed ID: 24386456
[TBL] [Abstract][Full Text] [Related]
38. Dynamic 2-Deoxy-2-[
Kristian A; Holtedahl JE; Torheim T; Futsaether C; Hernes E; Engebraaten O; Mælandsmo GM; Malinen E
Mol Imaging Biol; 2017 Apr; 19(2):271-279. PubMed ID: 27541026
[TBL] [Abstract][Full Text] [Related]
39. Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer.
Groheux D; Biard L; Lehmann-Che J; Teixeira L; Bouhidel FA; Poirot B; Bertheau P; Merlet P; Espié M; Resche-Rigon M; Sotiriou C; de Cremoux P
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1279-1288. PubMed ID: 29616304
[TBL] [Abstract][Full Text] [Related]
40. Lymph node standardized uptake values at pre-treatment
Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
